PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Alexa Fluor® 647 anti-Tubulin-α, 100 μg
Alexa Fluor® 647 anti-Vimentin, 25 μg
Alexa Fluor® 647 anti-XBP-1s, 100 tests
Alexa Fluor® 647 anti-XBP-1s, 25 tests
Alexa Fluor® 647 anti-ZAP70 Phospho (Tyr292), 100 tests
Alexa Fluor® 647 anti-ZAP70 Phospho (Tyr292), 25 tests
Alexa Fluor® 647 anti-ZAP70 Phospho (Tyr319)/Syk Phospho (Tyr352), 100 tests
Alexa Fluor® 647 anti-ZAP70 Phospho (Tyr319)/Syk Phospho (Tyr352), 25 tests
Alexa Fluor® 647 anti-β-actin, 100 μg
Alexa Fluor® 700 anti-mouse Ki-67, 100 μg
Alexa Fluor® 700 anti-mouse Ki-67, 25 μg
Anti-c-Myc Tag (9E10) Affinity Gel, 500 μl
Anti-DYKDDDDK Tag (L5) Affinity Gel, 2 ml
Anti-DYKDDDDK Tag (L5) Affinity Gel, 5 ml
Anti-DYKDDDDK Tag (L5) Affinity Gel, 500 μl
Anti-E. coli RNA Polymerase ImmunoAffinity Resin, 1 ml